PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 191 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.40 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $475,000 | +0.6% | 12,582 | -12.8% | 0.00% | 0.0% |
Q1 2018 | $472,000 | -55.1% | 14,437 | -33.1% | 0.00% | -57.1% |
Q4 2017 | $1,051,000 | +266.2% | 21,582 | +306.4% | 0.01% | +250.0% |
Q3 2017 | $287,000 | +13.4% | 5,310 | +18.0% | 0.00% | 0.0% |
Q2 2017 | $253,000 | +36.0% | 4,501 | -42.9% | 0.00% | +100.0% |
Q2 2016 | $186,000 | +34.8% | 7,889 | +16.9% | 0.00% | 0.0% |
Q1 2016 | $138,000 | -39.5% | 6,749 | +52.3% | 0.00% | -50.0% |
Q4 2015 | $228,000 | -0.9% | 4,430 | -18.0% | 0.00% | 0.0% |
Q3 2015 | $230,000 | +202.6% | 5,405 | +222.9% | 0.00% | +100.0% |
Q2 2015 | $76,000 | +68.9% | 1,674 | +42.0% | 0.00% | – |
Q1 2015 | $45,000 | +40.6% | 1,179 | +3.4% | 0.00% | – |
Q4 2014 | $32,000 | +14.3% | 1,140 | +2.2% | 0.00% | – |
Q3 2014 | $28,000 | -15.2% | 1,116 | -2.7% | 0.00% | – |
Q2 2014 | $33,000 | +37.5% | 1,147 | +22.9% | 0.00% | – |
Q1 2014 | $24,000 | +41.2% | 933 | +40.1% | 0.00% | – |
Q4 2013 | $17,000 | – | 666 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 232,952 | $5,498,000 | 5.39% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,673,727 | $86,700,000 | 3.41% |
Redmile Group, LLC | 1,466,537 | $34,610,000 | 3.31% |
SECTORAL ASSET MANAGEMENT INC | 1,229,382 | $29,013,000 | 3.00% |
HARVEY CAPITAL MANAGEMENT INC | 206,530 | $4,874,000 | 2.44% |
Marcus Capital, LLC | 75,150 | $1,774,000 | 1.87% |
Cormorant Asset Management, LP | 396,000 | $9,346,000 | 1.32% |
Rail-Splitter Capital Management, LLC | 221,414 | $5,225,000 | 1.25% |
Temasek Holdings (Private) Ltd | 6,583,568 | $155,372,000 | 1.21% |
EMERALD MUTUAL FUND ADVISERS TRUST | 636,526 | $15,022,000 | 0.84% |